There is evidence that HMGB1 can be released from macrophages during apoptosis [27,28], and that bortezomib induces apoptosis of cancer cells through stabilization and inhibition of proteasomal degradation of pro-apoptotic proteins such as p53 and IκB [32,33,34]. This evidence concerns the gene TP53 and cancer.